This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignees: The Austin Research Institute, The University of Melbourne, Consolidated Pharmaceuticals, Limited. Active years: 1991-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Brunswick, AU (1992 - 1998)
- Brunswick West, AU (1998)
- Victoria, AU (1999)
- Brunswick, AU (1991 - 2000)
Company Filing History:

Years Active: 1991-2000
Title: Ian F McKenzie: Innovator in Immunotherapy
Introduction
Ian F McKenzie is a prominent inventor based in Brunswick, Australia. He has made significant contributions to the field of immunotherapy, holding a total of nine patents. His work focuses on the production of proteins in host cells and the development of immunogenic vaccines.
Latest Patents
Among his latest patents, McKenzie has developed methods for producing antigen carbohydrate compounds that are utilized in immunotherapy. These patents describe conjugates that consist of one or more repeated subunits of an antigen linked to a carbohydrate polymer. The conjugates are particularly effective in creating vaccines that induce cell-mediated immune responses. Notably, these conjugates may include polymers of the carbohydrate mannose combined with repeated subunits of human mucin.
Career Highlights
Throughout his career, Ian F McKenzie has worked with esteemed institutions such as the Austin Research Institute and the University of Melbourne. His research has significantly advanced the understanding of immunogenic responses and the potential for therapeutic applications.
Collaborations
McKenzie has collaborated with notable colleagues, including Mark P Hogarth and Margaret L Hibbs. Their joint efforts have contributed to the advancement of research in immunotherapy and related fields.
Conclusion
Ian F McKenzie is a distinguished inventor whose work in immunotherapy has led to innovative solutions and advancements in the field. His contributions continue to impact the development of effective vaccines and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile